×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
MARK3 Antikörper (C-Term)
MARK3
Reaktivität: Human
WB, IHC (p)
Wirt: Kaninchen
Polyclonal
RB2525
unconjugated
Produktdetails anti-MARK3 Antikörper
(ausblenden)
Target
Alle MARK3 Antikörper anzeigen
MARK3
(MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
Bindungsspezifität
Alle Epitope für MARK3 Antikörper
AA 570-601, C-Term
Reaktivität
Alle Reaktivitäten für MARK3 Antikörper
Human
Wirt
Alle Wirte für MARK3 Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für MARK3 Antikörper
Polyklonal
Konjugat
Alle Konjugate für MARK3 Antikörper
Dieser MARK3 Antikörper ist unkonjugiert
Applikation
Alle Applikationen für MARK3 Antikörper
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Homologie
M, Rat
Aufreinigung
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This MARK3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 570-601 amino acids from the C-terminal region of human MARK3.
Klon
RB2525
Isotyp
Ig Fraction
Top Product
Discover our top product MARK3 Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
WB: 1:1000. IHC-P: 1:50~100
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Haltbarkeit
6 months
Details zu MARK3
(ausblenden)
Target
MARK3
(MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
Andere Bezeichnung
MARK3 (MARK3 Produkte )
Synonyme
MARK3 antikoerper, par1 antikoerper, par-1 antikoerper, Par-1A antikoerper, CTAK1 antikoerper, KP78 antikoerper, PAR1A antikoerper, Par-1a antikoerper, 1600015G02Rik antikoerper, A430080F22Rik antikoerper, C-TAK1 antikoerper, ETK-1 antikoerper, ETK1 antikoerper, Emk2 antikoerper, MPK10 antikoerper, fi39g08 antikoerper, wu:fi39g08 antikoerper, zgc:152848 antikoerper, zgc:55693 antikoerper, c-tak1 antikoerper, ctak1 antikoerper, emk-2 antikoerper, microtubule affinity regulating kinase 3 antikoerper, MAP/microtubule affinity-regulating kinase 3b antikoerper, MAP/microtubule affinity regulating kinase 3 antikoerper, MAP/microtubule affinity-regulating kinase 3a antikoerper, microtubule affinity regulating kinase 3 L homeolog antikoerper, MARK3 antikoerper, mark3b antikoerper, mark3 antikoerper, Mark3 antikoerper, mark3a antikoerper, mark3.L antikoerper
Hintergrund
MARK proteins are involved in the specific phosphorylation of microtubule-associated proteins for tau, MAP2, and MAP4. MARK3 was originally identified as a marker that was induced by treatment with DNA damaging agents, and loss of MARK3 was found with carcinogenesis in the pancreas. MARK3 may be involved in cell cycle regulation, and alterations in the MARK3 gene may lead to carcinogenesis.
Molekulargewicht
84429
Gen-ID
4140
NCBI Accession
NP_001122390 , NP_001122391 , NP_001122392 , NP_001122393 , NP_002367
UniProt
P27448
Pathways
SARS-CoV-2 Protein Interaktom
Zuletzt angesehen
(ausblenden)